Vera Therapeutics, Inc Annual Shareholders Meeting Transcript
Good morning. My name is Marshall Fordyce, and I am Chief Executive Officer of Vera Therapeutics. I am very happy to welcome you to the Vera Therapeutics 2026 Annual Stockholders Meeting. The meeting will now officially come to order. The time is now 8 AM Pacific Time on Thursday, May 21, and the polls are now open for voting on all matters to be presented.
I want to thank you all for joining us. As we are hosting today's meeting through a virtual online platform hosted by Broadridge. In addition to myself, we are joined by members of the Board and executive team who are with us virtually today. Also in attendance are Katie Wechsler, and Jared Denham of KPMG LLP, the company's independent registered public accounting firm who are available to respond to appropriate questions after the proposals have been described.
We will proceed with the formal business of the meeting in the order set forth in the Notice of Annual Meeting and Proxy Statement. We will first present the three proposals
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
